20H·

Crazy Q2 figures

$MEDP (+4,31%)

Sales: 603M vs 539M expected

Net income: 90M vs 90M expected

EBITDA: 131M vs 117M expected

Book To Bill: 1.03 vs 0.9 prior


Outlook FY 2025


Sales: 2470M vs 2185M expected (the 2470 were not even expected for 2027)

Net Income: 416M vs 390M expected


Absolutely strong numbers. Unfortunately, I didn't dare to buy sooner because it didn't look good

9
Participar na conversa